FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

6837005: Dextropropoxyphene napsylate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2154299012 Dextropropoxyphene napsylate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2155320010 Propoxyphene napsylate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3497194011 Dextropropoxyphene napsylate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3142191000005113 propoxyphennapsylat da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dextropropoxyphene napsylate Is a Product containing dextropropoxyphene (medicinal product) false Inferred relationship Some
Dextropropoxyphene napsylate Is a Propoxyphene false Inferred relationship Some
Dextropropoxyphene napsylate Is a Opiate agonist (substance) false Inferred relationship Some
Dextropropoxyphene napsylate Is a Opioid receptor agonist false Inferred relationship Some
Dextropropoxyphene napsylate Is a Dextropropoxyphene (substance) false Inferred relationship Some
Dextropropoxyphene napsylate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Opioid receptor agonist (disposition) true Inferred relationship Some
Dextropropoxyphene napsylate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Dextropropoxyphene (substance) true Inferred relationship Some
Dextropropoxyphene napsylate Is a Drug allergen false Inferred relationship Some
Dextropropoxyphene napsylate Is a Methadone analog (substance) true Inferred relationship Some
Dextropropoxyphene napsylate Is a Propionate true Inferred relationship Some
Dextropropoxyphene napsylate Is a Amine and/or amine derivative true Inferred relationship Some
Dextropropoxyphene napsylate Is a Carboxylic ester (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely dextropropoxyphene napsylate 100 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextropropoxyphene napsylate Inferred relationship Some
propoxyphennapsylat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextropropoxyphene napsylate Inferred relationship Some
Dextropropoxyphene napsylate 50 mg and paracetamol 325 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextropropoxyphene napsylate Inferred relationship Some
Dextropropoxyphene napsylate 100 mg and paracetamol 650 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextropropoxyphene napsylate Inferred relationship Some
paracetamol + propoxyphennapsylat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextropropoxyphene napsylate Inferred relationship Some
Dextropropoxyphene napsylate 100 mg and paracetamol 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextropropoxyphene napsylate Inferred relationship Some
Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextropropoxyphene napsylate Inferred relationship Some
Product containing precisely dextropropoxyphene napsylate 100 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextropropoxyphene napsylate Inferred relationship Some 1
Product containing precisely dextropropoxyphene napsylate 100 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Dextropropoxyphene napsylate Inferred relationship Some 1
Dextropropoxyphene napsylate 50 mg and paracetamol 325 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextropropoxyphene napsylate Inferred relationship Some 2
Dextropropoxyphene napsylate 50 mg and paracetamol 325 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Dextropropoxyphene napsylate Inferred relationship Some 2
Dextropropoxyphene napsylate 100 mg and paracetamol 650 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Dextropropoxyphene napsylate Inferred relationship Some 2
Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextropropoxyphene napsylate Inferred relationship Some 2
Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Dextropropoxyphene napsylate Inferred relationship Some 2
Dextropropoxyphene napsylate 100 mg and paracetamol 650 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextropropoxyphene napsylate Inferred relationship Some 1
Dextropropoxyphene napsylate 100 mg and paracetamol 650 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Dextropropoxyphene napsylate Inferred relationship Some 1
Dextropropoxyphene napsylate 100 mg and paracetamol 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextropropoxyphene napsylate Inferred relationship Some 2
Dextropropoxyphene napsylate 100 mg and paracetamol 500 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Dextropropoxyphene napsylate Inferred relationship Some 2
Dextropropoxyphene napsylate monohydrate (substance) Is a False Dextropropoxyphene napsylate Inferred relationship Some
Dextropropoxyphene napsylate monohydrate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Dextropropoxyphene napsylate Inferred relationship Some
Dextropropoxyphene napsylate 100 mg and paracetamol 650 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dextropropoxyphene napsylate Inferred relationship Some 2
Product containing precisely dextropropoxyphene napsylate 100 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dextropropoxyphene napsylate Inferred relationship Some 1
Dextropropoxyphene napsylate 100 mg and paracetamol 500 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dextropropoxyphene napsylate Inferred relationship Some 2
Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dextropropoxyphene napsylate Inferred relationship Some 2
Dextropropoxyphene napsylate 50 mg and paracetamol 325 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dextropropoxyphene napsylate Inferred relationship Some 2

This concept is not in any reference sets

Back to Start